How fast will I lose weight on GLP-1s and is it sustainable?

GLP-1 medications are powerful tools for weight loss, but it's important to have realistic expectations about the speed and sustainability.

How Fast Will You Lose Weight on GLP-1s?

Weight loss on GLP-1s is typically gradual but significant, and it varies from person to person. It's not a rapid, overnight change.

1. Initial Phase (First 3-6 months): You'll usually start on a low dose, which is gradually increased over several weeks or months to minimize side effects. During this titration period, weight loss might be slower, but consistent. Many people start to see noticeable changes within the first few weeks or months.
2. Peak Weight Loss (6-18 months): Most people achieve their maximal weight loss around 6 to 18 months of treatment. Clinical trials have shown impressive results:
   • Wegovy (semaglutide): In clinical trials, participants without diabetes lost an average of about 15% of their initial body weight over 68 weeks (about 1.3 years) at the highest dose.
   • Zepbound (tirzepatide): In trials for individuals without diabetes, participants on the highest dose lost an average of 20-22.5% of their initial body weight over 72 weeks (about 1.4 years).

Key Factors Influencing Speed:

• Individual Response: Metabolism, genetics, and how your body reacts to the medication all play a role.
• Dose Titration: How quickly your doctor increases your dose.
• Lifestyle Changes: Combining the medication with dietary changes (reduced calorie intake, healthier food choices) and regular physical activity will accelerate and enhance weight loss.

Is It Sustainable?

Yes, but with critical caveats. GLP-1s are considered chronic medications, meaning they are designed for long-term use, similar to medications for high blood pressure or high cholesterol.

Factors for Sustainability:

1. Continuous Medication Use: The weight loss effects of GLP-1s generally persist as long as you continue taking the medication. If you stop, appetite often returns to pre-treatment levels, and the slowed gastric emptying effect diminishes, leading to weight regain in most individuals. This is why they are considered a long-term treatment for a chronic disease (obesity).
2. Lifestyle Integration: GLP-1s are powerful tools, but they are most effective when combined with healthy lifestyle habits. This includes:
   • Nutrient-dense diet: Focusing on whole foods, lean proteins, fruits, and vegetables.
   • Regular physical activity: Exercise not only aids weight loss but also improves overall health and helps maintain muscle mass.
   • Behavioral changes: Learning new eating habits, managing stress, and improving your relationship with food are crucial for long-term success. The medication helps you adhere to these changes by reducing hunger and cravings.
3. Medical Supervision: Ongoing medical care from a doctor or obesity specialist is essential to monitor your progress, manage side effects, adjust dosages, and address any other health concerns.
4. Cost and Insurance Coverage: This is a major practical hurdle for many. GLP-1 medications can be very expensive (often over $1,000 per month without insurance). Sustained use depends heavily on your insurance coverage or your ability to pay out-of-pocket. Advocate for coverage with your insurance provider or explore patient assistance programs if available.

Recommended Brands & Services:

For Weight Loss (FDA-Approved):

• Wegovy (semaglutide): This is specifically FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It's an injectable medication taken once weekly.
• Zepbound (tirzepatide): Also FDA-approved for chronic weight management. It often shows slightly greater weight loss than semaglutide in studies and is also a once-weekly injection.

For Diabetes (Often Used Off-Label for Weight Loss):

• Ozempic (semaglutide): Primarily FDA-approved for Type 2 Diabetes, but it contains the same active ingredient as Wegovy and is often prescribed off-label for weight loss, especially when Wegovy is unavailable or not covered.
• Mounjaro (tirzepatide): Primarily FDA-approved for Type 2 Diabetes, it contains the same active ingredient as Zepbound and is also frequently used off-label for weight loss.

For Access and Support:

• Your Primary Care Provider or an Obesity Medicine Specialist: The best first step. They can assess your suitability, discuss options, prescribe medication, and provide ongoing medical supervision.
• Telehealth Services Specializing in Weight Management:
  • WeightWatchers Clinic (formerly Sequence): Offers comprehensive medical weight management, including prescription GLP-1s (if appropriate), registered dietitian support, and fitness coaching, all delivered virtually.
  • Found: Another online platform that connects you with clinicians for medication management, health coaching, and support for sustainable weight loss.

In summary, GLP-1s offer a promising path to significant and sustainable weight loss for many, but they are not a quick fix. They require ongoing medication, commitment to lifestyle changes, and continuous medical supervision.